v3.24.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating expenses:    
General and administrative $ 5,983,255 $ 5,829,799
Research and development 11,894,315 8,602,954
Total operating expenses 17,877,570 14,432,753
Loss from operations (17,877,570) (14,432,753)
Interest income 765,388 204,355
Other income (expense), net 1,150,648 (31,548)
NET LOSS $ (15,961,534) $ (14,259,946)
Net loss per share of common shares, basic $ (1.47) $ (1.31)
Net loss per share of common shares, diluted $ (1.47) $ (1.31)
Weighted-average number of common shares outstanding, basic 10,842,365 10,850,579
Weighted-average number of common shares outstanding, diluted 10,842,365 10,850,579

Source